Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vistra Corp (VST) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Vistra CorpTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Vistra Corp vs Zimmer Biomet Holdings Inc — how do they compare? Vistra Corp trades at $162.59 (market cap $53.27B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Vistra Corp is far larger — about 3.1× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.

VSTZBH
Market Cap
$53.27B$17.36B
Sector
TechnologyHealth
52-Week High
$217.92$107.71
52-Week Low
$134.71$79.58
Enterprise Value
$75.03B$24.40B
Dividend Yield
0.58%1.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vistra Corp

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.

The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH